Neisseria meningitidis (the meningococcus) causes significant morbidity and mortality in
children and young adults worldwide through epidemic or sporadic meningitis and/or …

Introduction Invasive meningococcal disease (IMD) is uncommon but still causes
considerable public health burden due to its high mortality and morbidity. This review aims …

England and Wales are experiencing a year-on-year increase in meningococcal group W
(MenW) disease since 2009–2010, following rapid expansion of a single endemic …

We assess risks of communicable diseases that are associated with mass gatherings (MGs),
outline approaches to risk assessment and mitigation, and draw attention to some key …

This review details the impact of the introduction of meningococcal serogroup C conjugate
(MCC) vaccines in the UK. An overall reduction of 86.7% in the incidence of serogroup C …

The laboratory confirmation of meningococcal disease and characterization of Neisseria
meningitidis isolates was improved considerably in England and Wales by the …

Since the epidemiological year 2009/10, the United Kingdom has experienced a year-on-
year increase in meningococcal group W (MenW) disease due to rapid expansion of a …

Following an outbreak in Mecca Saudi Arabia in 2000, meningococcal strains expressing
capsular group W (W) emerged as a major cause of invasive meningococcal disease (IMD) …

In 2015, the UK became the first country in the world to have a comprehensive routine
meningococcal vaccine programme targeting all of the main capsular groups of N …

Serum samples from children immunized with a meningococcal serogroup B vaccine
demonstrated potent serum bactericidal antibody activity against the hypervirulent Neisseria …